NovaQuest Capital Management has agreed to acquire Viamet Pharmaceuticals, according to a news release.
Viamet, based in Durham, N.C., is a biopharmaceutical company focused on the discovery, development and commercialization of antifungal agents based on its proprietary metalloenzyme medicinal chemistry platform.
NovaQuest Capital Management, based in Raleigh, N.C., is private equity and venture capital firm focused on investing in life sciences and healthcare through its NovaQuest Biopharma and NovaQuest Private Equity platforms. NovaQuest Private Equity targets companies in the middle market.
Financial terms were not disclosed.